Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas

Conditions:   Malignant Neoplasms of Thyroid and Other Endocrine Glands;   Anaplastic Thyroid Carcinoma;   Poorly Differentiated Thyroid Cancer Interventions:   Drug: Nab-paclitaxel - INDUCTION COHORT;   Drug: Paclitaxel - INDUCTION COHORT;   Drug: Vemurafenib - COHORT 1;   Drug: Cobimetinib - COHORT 1;   Drug: Atezolizumab - COHORT 1;   Drug: Bevacizumab - COHORT 3;   Drug: Nab-paclitaxel - COHORT 4;   Drug: Paclitax el - COHORT 4;   Drug: Cobimetinib - COHORT 2;   Drug: Atezolizumab - COHORT 2;   Drug: Atezolizumab - COHORT 3;   Drug: Atezolizumab - COHORT 4 Sponsors:   M.D. Anderson Cancer Center;   Genentech, Inc. Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2s93hUo
via IFTTT